[{"NetIncomeLoss_1_Q2_USD":-8269000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":-8513000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":45031000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":45137000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":7975000.0,"InterestPaidNet_2_Q2_USD":3000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":5657000.0,"InventoryFinishedGoods_0_Q2_USD":51000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":146000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":25954000.0,"Depreciation_2_Q2_USD":1100000.0,"Depreciation_1_Q2_USD":500000.0,"Investments_0_Q2_USD":25100000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":115762000.0,"OperatingLeaseExpense_2_Q2_USD":2900000.0,"OperatingLeaseExpense_1_Q2_USD":1400000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":34555000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":16486000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":93000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":18582000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":8660000.0,"FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_0_Q2_USD":129000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":696000.0,"FinanceLeaseInterestExpense_1_Q2_USD":100000.0,"FinanceLeaseInterestExpense_2_Q2_USD":100000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"ForeignCurrencyTransactionGainLossRealized_2_Q2_USD":-45000.0,"Liabilities_0_Q2_USD":39095000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":55704000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3226000.0,"InventoryRawMaterials_0_Q2_USD":7853000.0,"AllowanceForDoubtfulOtherReceivablesCurrent_0_Q2_USD":4400000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":84000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":125000.0,"AccruedBonusesCurrent_0_Q2_USD":2872000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":27000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":10000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-57000.0,"AccountsReceivableNetCurrent_0_Q2_USD":23655000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"CommonStockValue_0_Q2_USD":499103000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":20881000.0,"Revenues_2_Q2_USD":46692000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":0.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":-53000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1079000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1196000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_Q2_USD":17178000.0,"RestrictedCash_0_Q2_USD":100000.0,"OtherAssetsCurrent_0_Q2_USD":2900000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1601000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-12849000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-8185000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1692000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_Q2_USD":10138000.0,"Revenues_1_Q2_USD":20014000.0,"CommonStockSharesIssued_0_Q2_shares":45194000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":70071000.0,"Assets_0_Q2_USD":146691000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-391653000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":28815000.0,"CommonStockSharesOutstanding_0_Q2_shares":45194000.0,"RestrictedCashNoncurrent_0_Q2_USD":89000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":145000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":163000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4376000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1665000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":-30000.0,"InventoryWorkInProcess_0_Q2_USD":513000.0,"LiabilitiesCurrent_0_Q2_USD":18121000.0,"AccountsPayableCurrent_0_Q2_USD":4535000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":32797000.0,"NonoperatingIncomeExpense_2_Q2_USD":460000.0,"InterestExpense_2_Q2_USD":3000.0,"InterestExpense_1_Q2_USD":1000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":55793000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1373000.0,"GrossProfit_2_Q2_USD":28110000.0,"GrossProfit_1_Q2_USD":11354000.0,"ShortTermLeaseCost_2_Q2_USD":100000.0,"ShortTermLeaseCost_1_Q2_USD":100000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":257000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":55000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-14000.0,"NetIncomeLoss_2_Q2_USD":-12974000.0,"NonoperatingIncomeExpense_1_Q2_USD":89000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":25000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":69926000.0,"ShareBasedCompensation_2_Q2_USD":8144000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":23800000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q2_USD":7040000.0,"CommonStockSharesAuthorized_0_Q2_shares":75000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":46692000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":20014000.0,"OperatingIncomeLoss_2_Q2_USD":-13434000.0,"OperatingIncomeLoss_1_Q2_USD":-8358000.0,"InventoryNet_0_Q2_USD":8417000.0,"InvestmentIncomeInterest_2_Q2_USD":453000.0,"InvestmentIncomeInterest_1_Q2_USD":147000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":146691000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2578000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":129000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5570000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":429000.0,"OperatingExpenses_2_Q2_USD":41544000.0,"OperatingExpenses_1_Q2_USD":19712000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.29,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.18,"OtherLiabilitiesNoncurrent_0_Q2_USD":93000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":41000.0,"OtherLiabilitiesCurrent_0_Q2_USD":41000.0,"StockholdersEquity_0_Q2_USD":107596000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1186000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":207000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":6989000.0,"ShortTermInvestments_0_Q2_USD":25086000.0,"Ticker":"VCEL","CIK":"887359","name":"VERICEL CORP","OfficialName":"Vericel Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1756775066.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]